Daniel is a Professor of Breast Surgery, working in the Departments of BioSurgery and Surgical Technology, the Hamlyn Centre for Robotic Surgery and the Cancer Research UK Centre at Imperial College London. He is also a Consultant in Oncoplastic Breast Surgery working within the Breast Unit at Imperial College Healthcare NHS Trust.

Daniel trained at several centres of excellence in oncoplastic breast cancer and reconstructive breast surgery including the Imperial Breast Unit, and the Royal Marsden NHS Foundation Trust. He holds a Masters of Surgery Degree in Oncoplastic Breast Surgery, in which he won the “Issac Gukas Medal” for outstanding achievement. He was competitively selected for a National Training Fellowship (one of only nine such posts in the UK) and completed Advanced Oncoplastic Breast Surgery training at the St Andrews Centre for Plastic Surgery and Burns, as well as the Breast Unit at Broomfield Hospital in Chelmsford. Daniel leads a team whose main research goals are to improve the precision of breast surgery, optimising the sequence of therapy and enhancing convalescence following breast cancer treatment. He is the Chief Investigator of the NIHR-HTA funded, pan-UK, multicentre “PRADAII Trial” which seeks to find out whether reversing the sequence of radiation therapy improves breast related quality of life for women undergoing mastectomy and reconstruction using their own body tissues.

Daniel is also the Co-Lead on the CRUK funded “REI-EXCISE” trial which seeks to validate a mass-spectrometry based intelligent knife or “iKnife” as an immediate margin detection system to improve the precision of breast conserving surgery, reduce re-operative intervention, and enhance quality of life. He leads a UK wide team working on a CRUK-EPSRC funded project “MAMMOBOT” to design a flexible growing ductoscopic robot for early breast cancer detection. Daniel Co-Chairs the “Precision Therapy” theme of Imperial’s CRUK Centre and represents cancer surgery for the Imperial ECMC. Daniel lead a major national quality improvement initiative investigating Mastitis and Mammary Abscess Management (“MAMMA”) http://mammastudy.com/, and is the Chief Investigator of the NIHR-RfPB funded MAMMA-VAD trial investigating the role of vacuum treatment for breast abscess. He is the chief investigator of the NIHR HTA funded PRADA-II Trial which is an RCT investigating the potential benefits of preoperative radiotherapy on autologous reconstructive outcomes and improvements in breast related quality of life.

He has published over 200 scientific papers in peer-reviewed journals on subjects relating to the application of surgical technologies, sensing and robotics to improve cancer surgery. Daniel’s research has won national and international recognition, including the Hounsfield Prize, British Journal of Surgery Prize (ABS), Patey Prize (SARS), Sir Pat Forrest Award (BBG), Parasuraman Award, Athanasiou Medal (ABME), and the young scientist award nomination at MICCAI. He has attracted funding from Industry (Waters Corp, Hitachi Medical Corp, Samantree, and Stryker), the Academy of Medical Sciences and Wellcome Trust, Engineering and Physical Sciences Research Council, Association of Breast Surgery, Cancer Research UK, and the National Institute for Health and Care Research.